May 154 minAcesion Pharma Announces Positive Pre-Clinical Data for AP31969Copenhagen, Denmark – Acesion Pharma (“Acesion” or “the Company”), a biotech company pioneering first-in-class novel therapies for atrial...
Mar 145 minPositive phase 2 data from Atrial Fibrillation clinical trial – primary endpoint metFirst-in-class SK channel inhibition proof of mechanism achieved First new approach to treating Atrial Fibrillation for 20 years...
May 5, 20202 minAcesion Pharma Strengthens Clinical Team with Key Appointments Acesion Pharma, a Danish pharmaceutical company developing novel treatments for atrial fibrillation (AF), the most common cardiac...